| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of*
Rheumatology and Inflammation Research, and Medical Microbiology and Immunology, Göteborg University, Göteborg, Sweden
We show, for the first time, that the transcription factor T-bet, which is implicated in IFN-
production, is required for the induction of vaccine-induced antiviral immune protection. T-bet was found to be important in both the innate and acquired immune protection against genital HSV-2 infection. T-bet–/– and T-bet+/+ mice were infected vaginally with HSV-2 and examined daily for disease and mortality. T-bet–/– mice had significantly higher virus titers than T-bet+/+ mice following a primary HSV-2 infection, and succumbed significantly earlier to the infection. This result was associated with an impaired NK cell cytotoxic capacity and NK cell-mediated IFN- production in the T-bet–/– mice. To assess the induction of acquired antiviral immune protection, mice were vaccinated with an attenuated virus before infection. Vaccinated T-bet–/– mice could not control viral replication following an HSV-2 challenge and had significantly higher virus titers and mortality rates than vaccinated T-bet+/+ mice that remained healthy. The impaired acquired immune protection in T-bet–/– mice was associated with a significantly decreased HSV-2-specific delayed-type hypersensitivity response and a significantly reduced HSV-2-specific IFN- production from CD4+ T cells. However, T-bet deficiency did not impair either the IFN- production or the cytotoxic capacity of HSV-2-specific CD8+ T cells. We conclude that T-bet plays a crucial role in both the innate defense and the generation of vaccine-induced immunity against genital HSV-2 infection in mice.
This article has been cited by other articles:
|
|
 |
|
  S. Guo, D. Cobb, and R. B. Smeltz T-bet Inhibits the In Vivo Differentiation of Parasite-Specific CD4+ Th17 Cells in a T Cell-Intrinsic Manner J. Immunol., May 15, 2009; 182(10): 6179 - 6186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gill and A. A. Ashkar Overexpression of Interleukin-15 Compromises CD4-Dependent Adaptive Immune Responses against Herpes Simplex Virus 2 J. Virol., January 15, 2009; 83(2): 918 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Svensson, A.-M. H. Bergin, G.-B. Lowhagen, P. Tunback, L. Bellner, L. Padyukov, and K. Eriksson A 3'-untranslated region polymorphism in the TBX21 gene encoding T-bet is a risk factor for genital herpes simplex virus type 2 infection in humans J. Gen. Virol., September 1, 2008; 89(9): 2262 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Owaki, M. Asakawa, F. Fukai, J. Mizuguchi, and T. Yoshimoto IL-27 Induces Th1 Differentiation via p38 MAPK/T-bet- and Intercellular Adhesion Molecule-1/LFA-1/ERK1/2-Dependent Pathways J. Immunol., December 1, 2006; 177(11): 7579 - 7587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, A. L. Mora, J. LaVoy, K. L. Brigham, and M. Rojas Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L658 - L667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Kersh Impaired Memory CD8 T Cell Development in the Absence of Methyl-CpG-Binding Domain Protein 2 J. Immunol., September 15, 2006; 177(6): 3821 - 3826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matsui, O. Moriya, T. Yoshimoto, and T. Akatsuka T-bet Is Required for Protection against Vaccinia Virus Infection J. Virol., October 15, 2005; 79(20): 12798 - 12806. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
